Senior Director, Patient-Centred Outcomes Strategy & HTA Biometry
Job Summary
Title:
Senior Director Patient-Centred Outcomes Strategy & HTA BiometryCompany:
Ipsen Biopharm LtdAbout Ipsen:
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global hubs in the U.S. France and the U.K we tackle areas of high unmet medical need through research and innovation.
Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration excellence and impact. At Ipsen every individual is empowered to be their true selves grow and thrive alongside the companys success. Join us on our journey towards sustainable growth creating real impact on patients and society!
For more information visit us at follow our latest news on LinkedIn and Instagram.
Job Description:
WHAT - Summary & Purpose of the Position
The Senior Director Patient-Centred Outcomes Strategy & Heath Technology Assessment (HTA) Biometry provides enterprise leadership for COA (Clinical Outcome Assessment) strategy across Ipsens R&D portfolio with specific accountability for Patient Reported Outcomes (PRO) strategy questionnaire development measurement strategy validation implementation and interpretation.
The role ensures patient experience symptoms functioning quality of life treatment burden and treatment benefit are captured robustly and integrated into development strategy study documents regulatory interactions publications and value evidence materials.
In parallel the role leads HTA Biometry including statistics and programming supporting HTA reimbursement payer evidence comparative effectiveness evidence synthesis and value demonstration with accountability for quality timelines prioritization execution and internal or outsourced delivery.
Working in a global matrix the role partners with Clinical Development Global Value and Access including HEOR Regulatory Affairs Medical Writing Clinical Operations Data Management vendors and external experts to build capability develop talent drive excellence promote innovation and position Biometry as a strategic partner in patient-centered evidence and HTA decision support.
WHAT - Main Responsibilities & Technical Competencies
PRO / COA remit
Lead R&D COA measurement strategy across Ipsen programs with deep expertise in PRO strategy and questionnaire development.
Advise on disease models concepts of interest endpoint selection questionnaire development validation treatment-benefit interpretation and patient-focused evidence plans.
Embed COA strategies into development plans protocols SAPs regulatory documents reports publications HTA materials and value evidence outputs.
Serve as SME for patient-centered outcomes PROs broader COAs HRQoL symptoms function treatment burden PFDD and fit-for-purpose measurement.
HTA Biometry remit
Lead coach and develop the HTA Statistics and Programming team supporting Global Evidence & Outcomes with HEOR including workforce planning prioritization capability development performance support succession planning and operating model.
Set priorities standards quality expectations documentation requirements resourcing plans and capability roadmaps for HTA statistical analysis and programming.
Oversee analyses supporting HTA submissions reimbursement comparative effectiveness evidence synthesis RWE external controls and value demonstration.
Ensure internal and outsourced outputs are high quality compliant reproducible and delivered to agreed timelines and budget using standard processes templates SOPs and tools.
Cross-remit leadership
Advance tools automation AI-enabled approaches and innovative methods to improve efficiency quality and scalability across PRO/COA and HTA Biometry deliverables.
Partner with Clinical Development Global Value and Access including HEOR Regulatory Affairs Medical Writing Clinical Operations Data Management and external experts on integrated patient-centered and HTA evidence strategies.
Represent Biometry in governance asset teams portfolio discussions external scientific interactions and due diligence requiring COA PRO or HTA Biometry input.
HOW - Behavioural Competencies Required
Competency Behavioural Markers Rationale
Ensures Accountability
Assigns clear ownership for tasks/projects
Clarifies accountabilities and coaches others to do the same
Seeks stakeholder input and drives consent-based decisions
Owns decisions outcomes and follow-through Requires clear ownership of COA/PRO strategy and HTA analysis/programming quality compliance timelines and delivery.
Develops/Coaches Talent
Aligns development goals with business needs
Provides regular actionable coaching and feedback
Supports succession planning and team effectiveness
Builds a human-centred growth-focused culture
Leads and develops HTA Statistics and Programming while building COA/PRO methods delivery and influencing capability.
Drive Vision and Strategy
Creates a compelling vision and strategy that motivates action
Sets direction for COA/PRO and HTA biometry to support development strategy access readiness portfolio value and patient-centred evidence.
Manage Complexity
Resolves conflicting inputs and demands
Evaluates options and scenarios
Prioritises what matters and makes impact-driven decisions
Balances scientific clinical regulatory payer vendor statistical and programming priorities to make pragmatic decisions.
Communicates Effectively
Listens actively and respects different perspectives
Communicates transparently and respectfully
Creates clear structured outcome-focused messages
Demonstrates gravitas
Translates complex COA/PRO statistical programming and HTA topics into clear decision-ready messages for senior and cross-functional stakeholders.
HOW - Knowledge & Experience
Knowledge & Experience (essential):
10 years relevant pharma biotech CRO academic or outcomes research experience with PhD or equivalent MS/MSc experience including significant leadership experience.
Expertise in COA especially PROs including strategy questionnaire development selection validation implementation and interpretation.
Strong understanding of clinical development regulatory expectations and patient-centred evidence for treatment benefit.
Statistical and programming knowledge for HTA evidence reimbursement comparative effectiveness and value demonstration.
Team leadership experience including resourcing prioritisation quality oversight outsourced delivery coaching talent development and succession planning.
Experience contributing to development plans protocols SAPs reports CSRs regulatory packages HTA materials publications and presentations.
Strong global collaboration senior stakeholder influence and ability to translate complex concepts into clear decision-ready recommendations.
Knowledge & Experience (preferred):
Experience with ePRO digital COA/endpoints psychometrics or modern questionnaire development and implementation.
Experience with SAS and/or R programming concepts.
Experience in oncology rare disease or neuroscience drug development.
Scientific publication record or external presence in HTA or outcomes research.
Education / Certifications (essential):
MS/MSc or PhD in a relevant quantitative clinical outcomes psychometric or health outcomes discipline.
Language(s) (essential):
Fluent English with excellent written and verbal communication.
Required Experience:
Exec
About Company
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.